A Study of Single Ascending Dose of LEM-S401 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary objective of the study is to assess the safety and tolerability of single dose of LEM-S401 in healthy adult subjects.
Epistemonikos ID: 6e03611e0d578419255e1303db754e1fcaecfb0a
First added on: May 08, 2024